Current practices in gestational diabetes mellitus diagnosis and management in the United States: survey of maternal-fetal medicine specialists


Gestational diabetes mellitus (GDM) complicates 10% of pregnancies and leads to substantial perinatal complications that can be reduced with glycemic control.1 The extent of the treatment needed is based on a person’s glycemic response to medical nutritional therapy (MNT) and exercise. However, the definition of what constitutes an unsuccessful attempt at MNT and exercise has not been established.2 Consequently, the need to start pharmacotherapy is at the provider’s discretion with wide variability in practice.3,4 Based on this evidence gap, we developed and administered a survey for maternal-fetal medicine (MFM) providers to assess current practices in GDM, especially about pharmacotherapy initiation.

Document Type


PubMed ID


Link to Full Text